METLIFE INC — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that METLIFE INC filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $77.08B | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $70.99B | Feb 19, 2026 |
| FY2023 | Dec 31, 2023 | $19.03B | Feb 16, 2024 |
| FY2023 | Sep 30, 2023 | $15.87B | Feb 16, 2024 |
| FY2023 | Jun 30, 2023 | $16.62B | Feb 16, 2024 |
| FY2023 | Mar 31, 2023 | $15.39B | Feb 16, 2024 |
| FY2023 | Dec 31, 2022 | $15.61B | Feb 16, 2024 |
| FY2023 | Sep 30, 2022 | $22.28B | Feb 16, 2024 |
| FY2023 | Jun 30, 2022 | $15.47B | Feb 16, 2024 |
| FY2023 | Mar 31, 2022 | $15.41B | Feb 16, 2024 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.44B | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $2.25B | Feb 19, 2026 |
| FY2025 | Dec 31, 2023 | $2.23B | Feb 19, 2026 |
| FY2024 | Dec 31, 2022 | $2.11B | Feb 21, 2025 |
| FY2023 | Dec 31, 2021 | $2.07B | Feb 16, 2024 |
| FY2022 | Dec 31, 2020 | $1.35B | Feb 23, 2023 |
| FY2021 | Dec 31, 2019 | $1.29B | Feb 18, 2022 |
| FY2020 | Dec 31, 2018 | $1.26B | Feb 19, 2021 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.38B | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $4.43B | Feb 19, 2026 |
| FY2023 | Dec 31, 2023 | $607.00M | Feb 16, 2024 |
| FY2023 | Sep 30, 2023 | $489.00M | Feb 16, 2024 |
| FY2023 | Jun 30, 2023 | $402.00M | Feb 16, 2024 |
| FY2023 | Mar 31, 2023 | $80.00M | Feb 16, 2024 |
| FY2023 | Dec 31, 2022 | $1.58B | Feb 16, 2024 |
| FY2023 | Sep 30, 2022 | $1.16B | Feb 16, 2024 |
| FY2023 | Jun 30, 2022 | $910.00M | Feb 16, 2024 |
| FY2023 | Mar 31, 2022 | $1.63B | Feb 16, 2024 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $6.14B | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $6.00B | Feb 19, 2026 |
| FY2025 | Dec 31, 2023 | $5.72B | Feb 19, 2026 |
| FY2024 | Dec 31, 2022 | $5.98B | Feb 21, 2025 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $17.09B | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $14.60B | Feb 19, 2026 |
| FY2025 | Dec 31, 2023 | $13.72B | Feb 19, 2026 |
| FY2024 | Dec 31, 2022 | $13.04B | Feb 21, 2025 |
| FY2023 | Dec 31, 2021 | $12.35B | Feb 16, 2024 |
| FY2022 | Dec 31, 2020 | $11.64B | Feb 23, 2023 |
| FY2021 | Dec 31, 2019 | $13.79B | Feb 18, 2022 |
| FY2020 | Dec 31, 2018 | $11.74B | Feb 19, 2021 |
| FY2019 | Dec 31, 2017 | $12.28B | Feb 21, 2020 |
| FY2018 | Dec 31, 2016 | $14.77B | Feb 22, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $745.17B | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $677.46B | Feb 19, 2026 |
| FY2024 | Dec 31, 2023 | $687.58B | Feb 21, 2025 |
| FY2023 | Dec 31, 2022 | $663.07B | Feb 16, 2024 |
| FY2022 | Dec 31, 2021 | $759.71B | Feb 23, 2023 |
| FY2021 | Dec 31, 2020 | $795.15B | Feb 18, 2022 |
| FY2020 | Dec 31, 2019 | $740.46B | Feb 19, 2021 |
| FY2019 | Dec 31, 2018 | $687.54B | Feb 21, 2020 |
| FY2018 | Dec 31, 2017 | $719.89B | Feb 22, 2019 |
| FY2017 | Dec 31, 2016 | $898.76B | Mar 1, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $716.25B | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $649.75B | Feb 19, 2026 |
| FY2024 | Dec 31, 2023 | $657.33B | Feb 21, 2025 |
| FY2023 | Dec 31, 2022 | $632.95B | Feb 16, 2024 |
| FY2022 | Dec 31, 2021 | $691.96B | Feb 23, 2023 |
| FY2021 | Dec 31, 2020 | $720.33B | Feb 18, 2022 |
| FY2020 | Dec 31, 2019 | $674.08B | Feb 19, 2021 |
| FY2019 | Dec 31, 2018 | $634.58B | Feb 21, 2020 |
| FY2018 | Dec 31, 2017 | $661.02B | Feb 22, 2019 |
| FY2017 | Dec 31, 2016 | $831.06B | Mar 1, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $28.40B | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $27.45B | Feb 19, 2026 |
| FY2024 | Dec 31, 2023 | $30.02B | Feb 21, 2025 |
| FY2023 | Dec 31, 2022 | $29.88B | Feb 16, 2024 |
| FY2022 | Dec 31, 2021 | $67.48B | Feb 23, 2023 |
| FY2021 | Dec 31, 2020 | $74.56B | Feb 18, 2022 |
| FY2020 | Dec 31, 2019 | $66.14B | Feb 19, 2021 |
| FY2019 | Dec 31, 2018 | $52.74B | Feb 21, 2020 |
| FY2018 | Dec 31, 2017 | $58.68B | Feb 22, 2019 |
| FY2017 | Dec 31, 2016 | $67.53B | Mar 1, 2018 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $9.61B | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $8.90B | Feb 19, 2026 |
| FY2025 | Dec 31, 2023 | $9.24B | Feb 19, 2026 |
| FY2025 | Dec 31, 2022 | $9.30B | Feb 19, 2026 |
| FY2024 | Dec 31, 2021 | $9.54B | Feb 21, 2025 |
| FY2023 | Dec 31, 2020 | $10.11B | Feb 16, 2024 |
| FY2022 | Dec 31, 2019 | $9.31B | Feb 23, 2023 |
| FY2021 | Dec 31, 2018 | $9.42B | Feb 18, 2022 |
| FY2020 | Dec 31, 2017 | $9.59B | Feb 19, 2021 |
| FY2019 | Dec 31, 2016 | $9.22B | Feb 21, 2020 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $44.29B | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $42.63B | Feb 19, 2026 |
| FY2024 | Dec 31, 2023 | $40.15B | Feb 21, 2025 |
| FY2023 | Dec 31, 2022 | $40.33B | Feb 16, 2024 |
| FY2022 | Dec 31, 2021 | $41.20B | Feb 23, 2023 |
| FY2023 | Jan 1, 2021 | $31.82B | Feb 16, 2024 |
| FY2021 | Dec 31, 2020 | $36.49B | Feb 18, 2022 |
| FY2020 | Dec 31, 2019 | $33.08B | Feb 19, 2021 |
| FY2019 | Dec 31, 2018 | $28.93B | Feb 21, 2020 |
| FY2018 | Dec 31, 2017 | $26.53B | Feb 22, 2019 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $22.03B | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $20.07B | Feb 19, 2026 |
| FY2024 | Dec 31, 2023 | $20.64B | Feb 21, 2025 |
| FY2023 | Dec 31, 2022 | $20.20B | Feb 16, 2024 |
| FY2022 | Dec 31, 2021 | $20.05B | Feb 23, 2023 |
| FY2021 | Dec 31, 2020 | $19.80B | Feb 18, 2022 |
| FY2020 | Dec 31, 2019 | $16.60B | Feb 19, 2021 |
| FY2019 | Dec 31, 2018 | $15.82B | Feb 21, 2020 |
| FY2018 | Dec 31, 2017 | $12.70B | Feb 22, 2019 |
| FY2018 | Dec 31, 2016 | $12.65B | Feb 22, 2019 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2011 | Dec 31, 2011 | $23.69B | Feb 28, 2012 |
| FY2010 | Dec 31, 2010 | $27.59B | Feb 25, 2011 |
| FY2009 | Dec 31, 2009 | $13.22B | Feb 26, 2010 |
| FY2009 | Dec 31, 2008 | $9.67B | Feb 26, 2010 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 4 | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | 5 | Feb 19, 2026 |
| FY2023 | Dec 31, 2023 | 0 | Feb 16, 2024 |
| FY2023 | Sep 30, 2023 | 0 | Feb 16, 2024 |
| FY2023 | Jun 30, 2023 | 0 | Feb 16, 2024 |
| FY2023 | Mar 31, 2023 | 0 | Feb 16, 2024 |
| FY2023 | Dec 31, 2022 | 1 | Feb 16, 2024 |
| FY2023 | Sep 30, 2022 | 1 | Feb 16, 2024 |
| FY2023 | Jun 30, 2022 | 1 | Feb 16, 2024 |
| FY2023 | Mar 31, 2022 | 1 | Feb 16, 2024 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 4 | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | 5 | Feb 19, 2026 |
| FY2023 | Dec 31, 2023 | 0 | Feb 16, 2024 |
| FY2023 | Sep 30, 2023 | 0 | Feb 16, 2024 |
| FY2023 | Jun 30, 2023 | 0 | Feb 16, 2024 |
| FY2023 | Mar 31, 2023 | 0 | Feb 16, 2024 |
| FY2023 | Dec 31, 2022 | 1 | Feb 16, 2024 |
| FY2023 | Sep 30, 2022 | 1 | Feb 16, 2024 |
| FY2023 | Jun 30, 2022 | 1 | Feb 16, 2024 |
| FY2023 | Mar 31, 2022 | 1 | Feb 16, 2024 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 655.33M | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | 689.21M | Feb 19, 2026 |
| FY2024 | Dec 31, 2023 | 730.82M | Feb 21, 2025 |
| FY2023 | Dec 31, 2022 | 779.10M | Feb 16, 2024 |
| FY2022 | Dec 31, 2021 | 825.54M | Feb 23, 2023 |
| FY2021 | Dec 31, 2020 | 892.91M | Feb 18, 2022 |
| FY2020 | Dec 31, 2019 | 915.34M | Feb 19, 2021 |
| FY2019 | Dec 31, 2018 | 958.61M | Feb 21, 2020 |
| FY2018 | Dec 31, 2017 | 1.04B | Feb 22, 2019 |
| FY2017 | Dec 31, 2016 | 1.10B | Mar 1, 2018 |
Dividends Paid
Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.51B | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $1.53B | Feb 19, 2026 |
| FY2025 | Dec 31, 2023 | $1.57B | Feb 19, 2026 |
| FY2024 | Dec 31, 2022 | $1.60B | Feb 21, 2025 |
| FY2023 | Dec 31, 2021 | $1.65B | Feb 16, 2024 |
| FY2022 | Dec 31, 2020 | $1.66B | Feb 23, 2023 |
| FY2021 | Dec 31, 2019 | $1.64B | Feb 18, 2022 |
| FY2020 | Dec 31, 2018 | $1.68B | Feb 19, 2021 |
| FY2019 | Dec 31, 2017 | $1.72B | Feb 21, 2020 |
| FY2018 | Dec 31, 2016 | $1.74B | Feb 22, 2019 |